Zydus has said it has started human studies for its potential coronavirus vaccine. In its human trials, Zydus will enrol over 1,000 subjects.
![](https://i0.wp.com/sangathy.com/wp-content/uploads/2020/07/Zydus-begins-human-trials-for-potential-coronavirus-vaccine.png?resize=770%2C433&ssl=1)
Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.
ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.
In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.
You must be logged in to post a comment.